This is my first time at the American Society of Clinical Oncology meeting. I knew it was the premiere oncology meeting in the world, but I am pleased to see and experience the level of scientific progress and collaboration on display.
ASCO's theme this year is personalized medicine, which is fitting given GSK's approach to the future of treatment. It's clear that we need to provide more treatment options to patients with cancer.
In the last 55 years in the
It's important for us to be at ASCO. GSK is committed to this community and to ensuring that all stakeholders, physicians, nurses and patient groups have the tools they need to bring the right medicine to the right patient. And we also know it's our job that to make sure patients have access to those medicines--what's the point of developing great medicines if patients can't get them?
This past year has been an interesting one both for cancer research and awareness. There has been a lot of media coverage of a few high-profile celebrities going through cancer treatment, and the Stand Up to Cancer initiative has mobilized different groups to tackle this disease head-on. We're all focused on the same thing: finding the best ways to fight this disease--and win.
I'll admit, I wasn't all that familiar with Standup2cancer until their live ad with Katie Couric and Terrence Howard during this year's World Series game 3.
What an exciting initiative. I'm glad to find that they recently secured $100 million in funding for grants to groups proposing to have drugs in human trials in the next 3 years.
Laura Ziskin is a truly motivational leader and everything I've heard recently give me nothing but hope. I wish there were more, similarly vibrant groups out there getting noticed.
These are astounding numbers, They do however count in influenza and pneumonia and then they probably counted in a lot of other diseases which make the area cardiovascular, quite overall, I might be wrong.
In the article, they are discussing, if the nubmbers look more severe than they are in reality. I am however of the opinion that more can be done and must be done when it comes down to cancer, it will not be less deaths in the future and we should try to be as far as we can when it comes down to research and knowledge.